– National Highway Traffic Safety Administration
India Globalization Capita Just Got FDA Approval To Start Enrolling Their Phase 2 Alzheimer Trial With IGC-AD1, A Cannabis Drug
https://clinicaltrials.gov/ct2/show/NCT05543681
Brief Summary:
This is a superiority, parallel group, double blinded, randomized, powered, multi-site, and placebo-controlled study.
Ages 60 and above